Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Yousef Al-Shraideh; Samir V. Sejpal; Joshua J. Meeks

doi:10.1016/B978-0-12-800077-9.00031-1

Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Yousef Al-Shraideh, Samir V. Sejpal, Joshua J. Meeks

Division of Urologic Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

Original language	English
Title of host publication	Prostate Cancer
Subtitle of host publication	Science and Clinical Practice: Second Edition
Publisher	Elsevier Inc.
Pages	275-280
Number of pages	6
ISBN (Print)	9780128000779
DOIs	https://doi.org/10.1016/B978-0-12-800077-9.00031-1
State	Published - 2016

Keywords

Prostate cancer
PSA
Radiation treatment
Radical prostatectomy
Surgery

Access to Document

10.1016/B978-0-12-800077-9.00031-1

Cite this

@inbook{f29a8fd74a794ea3970e6ff307e768d7,

title = "Radiation-Resistant Prostate Cancer and Salvage Prostatectomy",

abstract = "One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.",

keywords = "Prostate cancer, PSA, Radiation treatment, Radical prostatectomy, Surgery",

author = "Yousef Al-Shraideh and Sejpal, {Samir V.} and Meeks, {Joshua J.}",

year = "2016",

doi = "10.1016/B978-0-12-800077-9.00031-1",

language = "English",

isbn = "9780128000779",

pages = "275--280",

booktitle = "Prostate Cancer",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

AU - Al-Shraideh, Yousef

AU - Sejpal, Samir V.

AU - Meeks, Joshua J.

PY - 2016

Y1 - 2016

N2 - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

AB - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

KW - Prostate cancer

KW - PSA

KW - Radiation treatment

KW - Radical prostatectomy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84966769133&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800077-9.00031-1

DO - 10.1016/B978-0-12-800077-9.00031-1

M3 - Chapter

AN - SCOPUS:84966769133

SN - 9780128000779

SP - 275

EP - 280

BT - Prostate Cancer

PB - Elsevier Inc.

ER -

Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this